Research and development - Press Releases

Date	Title	Company
22-Nov-2022	BOC Sciences Continues to Power Up RNA Therapeutics with siRNA Products and Services	BOC Sciences
22-Nov-2022	Hemophilia Treatment: New Insights Contribute to Minimize or Eliminate Side Effects in the Future	IMC Krems University of Applied Sciences
22-Nov-2022	Turbine raises €20m for AI platform to deliver targeted cancer treatments	Turbine
22-Nov-2022	The Cell and Gene Therapy Catapult marks ten years of ground-breaking collaborations and progress in the UK cell and gene therapy industry	The Cell and Gene Therapy Catapult
22-Nov-2022	OSE Immunotherapeutics Announces Publication of Peer-Reviewed Data on CLEC-1, its Novel Myeloid Immune Checkpoint in ‘Science Advances’	OSE Immunotherapeutics
21-Nov-2022	PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays	PerkinElmer, Inc.
21-Nov-2022	EDX Medical Group Plc announces European Cancer Biomarker Programme collaboration with Tianjin Bioscience Diagnostic Technology Co. Ltd	EDX Medical Group Plc
21-Nov-2022	Quell Therapeutics Appoints Luke Devey, BMBCh, Ph.D. as Chief Medical Officer	Quell Therapeutics
15-Nov-2022	Researchers make miniature ‘bone marrows in a dish’ to improve anti-cancer treatments	University of Birmingham
15-Nov-2022	Edmund Optics© Announces 2022 Educational Award and Norman Edmund Award Recipients	Edmund Optics©
15-Nov-2022	Boditech Med and SphingoTec close global licensing agreement for kidney function biomarker Proenkephalin A 119-159 (penKid)	Boditech Med and SphingoTec
15-Nov-2022	First completion of a full treatment workflow in the first European hospital-based BNCT facility	Neutron Therapeutics
15-Nov-2022	Precision Medicine Spend to Exceed $132 Billion Globally by 2027; Driven by Efficiency Gains for Healthcare Providers	Juniper Research
15-Nov-2022	ImmunOs Therapeutics´ Lead Program Shows Strong Anti-Tumor Activity In Vivo and In Vitro	ImmunOs Therapeutics
15-Nov-2022	ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022	ProQR Therapeutics N.V.
15-Nov-2022	Alfa Chemistry Launches Fluoropolymers as An ISO 9001:2015 Certified Supplier	Alfa Chemistry
14-Nov-2022	Save The Date: Molecure to Host Virtual R&D Day on 7th December 2022	Molecure S.A.
14-Nov-2022	Tecan and RevoluGen Enter into Agreement for 96-well Plates for Use in Automated Fire Monkey HMW-DNA Extraction Kits Ideal for Scalable DNA Sequencing	RevoluGen
10-Nov-2022	Transition Metal Complexes Are Ideal Compounds to Support Energy, Material, Biology, and Catalysis Research	Alfa Chemistry
09-Nov-2022	OSE Immunotherapeutics Builds a Strong R&D Strategy Through Innovative First-in-Class Multi-Platform Programs	OSE Immunotherapeutics